Navigation Links
Sosei Assigns AD 923 Assets to Pharmasol
Date:10/6/2009

TOKYO, October 6 /PRNewswire-FirstCall/ -- Sosei Group Corporation ("Sosei"; TSE Mothers Index: 4565), the biopharmaceutical company, today announced that Sosei R&D Ltd., its wholly owned UK subsidiary, has entered into an agreement to assign its rights to the assets of AD 923, an optimised, sublingual formulation of the opioid analgesic fentanyl for the treatment of cancer breakthrough pain, as well as to the device for drug administration to Pharmasol R&D Ltd. ("Pharmasol"), a privately held UK company.

The AD 923 development programme had previously entered Phase III clinical trials in Europe. However, due to the changes in regulatory environment, restructuring of Sosei R&D business operation, the programme had been halted.

Based on the present agreement Sosei R&D will receive payments from Pharmasol based on revenues arising from the commercialization of these assigned assets.

Editor's notes:

About Sosei

Sosei Group is a leading international biopharmaceutical company with significant expertise in product discovery and development. It has established a reduced risk business model primarily upon identifying new uses for established drugs and exploiting its unique position within Japanese, European and North American pharmaceutical markets by acquiring compounds from, and bringing compounds into, Japan.

For further information about Sosei, please visit http://www.sosei.com

About Pharmasol

Pharmasol Corporation engages in the contract manufacturing, packaging, and warehousing of aerosols, liquids, gels, and lotions for the health care and cosmetics industries. It also offers consultancy services, including research and development, purchasing, and marketing.

For further information about Pharmasol, please visit http://www.ph
'/>"/>

SOURCE Sosei Group Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Sosei Announces Completion of Phase III Trial for NorLevo(R)
2. Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting
3. Sosei Confirms the Safety of SD118 in Two Phase I Trials
4. Sosei and Vectura Announce Start of Phase III Clinical Study With NVA237
5. Bausch & Lomb Acquires the Commercial Assets of Italian Ophthalmic Pharmaceuticals Company Tubilux
6. ePharmaSolutions Clinical Trial Investigator Portal Wins Bio-IT World 2009 Best Practice Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2014)... 1, 2014 Reportbuyer.com has added a ... Aesthetic Lasers and Energy Devices Market Outlook to ... Brazil Aesthetic Lasers and Energy Devices ... GlobalData,s new report, "Brazil Aesthetic Lasers ... key market data on the Brazil Aesthetic Lasers ...
(Date:9/1/2014)... Sept. 1, 2014 Reportbuyer.com has ... Rigid Transparent Plastics: Global Markets Outside ... INTRODUCTION This chapter provides ... the study goals and objectives, reasons for ... information sources and analyst credentials, and related ...
(Date:8/30/2014)... , Aug. 30, 2014   Royal Philips  (NYSE: ... Affiniti, a new ultrasound system designed to enable ... of increasing patient volumes and cost pressures. Making its ... in Barcelona this week, ... more patients with fewer resources deliver high quality patient ...
Breaking Medicine Technology:Brazil Aesthetic Lasers and Energy Devices Market Outlook to 2020 2Brazil Aesthetic Lasers and Energy Devices Market Outlook to 2020 3Brazil Aesthetic Lasers and Energy Devices Market Outlook to 2020 4Brazil Aesthetic Lasers and Energy Devices Market Outlook to 2020 5Brazil Aesthetic Lasers and Energy Devices Market Outlook to 2020 6Brazil Aesthetic Lasers and Energy Devices Market Outlook to 2020 7Brazil Aesthetic Lasers and Energy Devices Market Outlook to 2020 8Brazil Aesthetic Lasers and Energy Devices Market Outlook to 2020 9Rigid Transparent Plastics: Global Markets Outside North America 2Rigid Transparent Plastics: Global Markets Outside North America 3Rigid Transparent Plastics: Global Markets Outside North America 4Rigid Transparent Plastics: Global Markets Outside North America 5Rigid Transparent Plastics: Global Markets Outside North America 6Rigid Transparent Plastics: Global Markets Outside North America 7Rigid Transparent Plastics: Global Markets Outside North America 8Rigid Transparent Plastics: Global Markets Outside North America 9Rigid Transparent Plastics: Global Markets Outside North America 10Rigid Transparent Plastics: Global Markets Outside North America 11Rigid Transparent Plastics: Global Markets Outside North America 12Rigid Transparent Plastics: Global Markets Outside North America 13Rigid Transparent Plastics: Global Markets Outside North America 14Rigid Transparent Plastics: Global Markets Outside North America 15Rigid Transparent Plastics: Global Markets Outside North America 16Rigid Transparent Plastics: Global Markets Outside North America 17Rigid Transparent Plastics: Global Markets Outside North America 18Rigid Transparent Plastics: Global Markets Outside North America 19Rigid Transparent Plastics: Global Markets Outside North America 20Rigid Transparent Plastics: Global Markets Outside North America 21Rigid Transparent Plastics: Global Markets Outside North America 22Rigid Transparent Plastics: Global Markets Outside North America 23Philips Debuts New Affiniti Ultrasound System at the European Society of Cardiology Congress 2014 2Philips Debuts New Affiniti Ultrasound System at the European Society of Cardiology Congress 2014 3Philips Debuts New Affiniti Ultrasound System at the European Society of Cardiology Congress 2014 4
... CITY, Calif., Feb. 23, 2011 Abaxis, Inc. (Nasdaq: ... analysis systems, announced today that Clint Severson, chairman and chief ... Conference on Thursday, March 3, 2011 at 10:00 a.m. ET. ... Hotel in New York City. A live webcast ...
... Foundation and Vertex Pharmaceuticals announced today that VX-770, an oral ... cystic fibrosis, showed promising results in a Phase 3 clinical ... patients age 12 and up who carry at least one ... 161 patients who received at least one dose of VX-770 ...
Cached Medicine Technology:Abaxis, Inc. to Present at RBC Capital Markets' Healthcare Conference 2Phase 3 Study of VX-770 Shows Marked Improvement in Lung Function Among People with Cystic Fibrosis with G551D Mutation 2Phase 3 Study of VX-770 Shows Marked Improvement in Lung Function Among People with Cystic Fibrosis with G551D Mutation 3
(Date:9/2/2014)... (PRWEB) September 02, 2014 Headaches, both chronic ... from going to work, enjoying family and friends, sleeping and ... is the single leading cause of disability worldwide. The ... carry serious risks. , Most of these cases of headache ... to treat them with prescriptions will not detect and fix ...
(Date:9/2/2014)... BESLER Consulting, a leading provider of Medicare ... to announce that it has released a special report ... 2015 Hospital Inpatient Prospective Payment System (IPPS) final rule ... Services. , “Hospitals are facing decreased Medicare reimbursements in ... BESLER’s President and Chief Executive Officer. “We are happy ...
(Date:9/2/2014)... 2014 With thoughts of getting the ... minds of many Washingtonians, it’s easy to forget that ... office managers to be booking their organizations’ holiday parties ... Washington, DC, area locations are preparing for the holiday ... for holiday parties, the space appears to be going ...
(Date:9/2/2014)... York (PRWEB) September 02, 2014 “Is ... is the question that millions of people ask. Diagnosing ... care providers, patients and their families or treatment partners. ... due to its distinct similarities to other skin conditions ... bed bug bites, eczema, varicella and many others. ...
(Date:9/2/2014)... OH (PRWEB) September 02, 2014 Request A ... testing, is offering a 10% discount on all drug testing ... savings, customers just need to use promo code DRUG10 when placing ... testing on urine, blood and hair. Drug testing is typically ... drugs. Some of the most popular panels include the ...
Breaking Medicine News(10 mins):Health News:Physical Therapists in Houston Learn Pain Relief Techniques 2Health News:Fall in Washington, DC, Is When a Meeting Planner’s Mind Turns to … the Winter Holidays? 2Health News:Fall in Washington, DC, Is When a Meeting Planner’s Mind Turns to … the Winter Holidays? 3Health News:Fall in Washington, DC, Is When a Meeting Planner’s Mind Turns to … the Winter Holidays? 4Health News:Fall in Washington, DC, Is When a Meeting Planner’s Mind Turns to … the Winter Holidays? 5Health News:New Breakthrough Formula - Dr. Scabies® : The New Industry Standard Treatment for Scabies to Fight the Scabies Breakout 2Health News:New Breakthrough Formula - Dr. Scabies® : The New Industry Standard Treatment for Scabies to Fight the Scabies Breakout 3Health News:New Breakthrough Formula - Dr. Scabies® : The New Industry Standard Treatment for Scabies to Fight the Scabies Breakout 4Health News:Request A Test Offers 10% Off Drug Testing in September 2014 2Health News:Request A Test Offers 10% Off Drug Testing in September 2014 3
... Information Technology to Meet Today,s Healthcare Challenges, ... Quantum Group,Inc. (AMEX: QGP, QGP.WSA, QGP.WSB) ... CEO, Noel J. Guillama has been asked ... Corporation,s 7th Annual Life,Science Conference, "Leveraging Information ...
... Limited-edition CD at Participating Giant Stores on Saturday, May 3 and ... ... ,Everyone,s a winner when you stop into participating Giant stores,throughout the Washington ... Game(R) Scoop Day event., This year, EDY,S Grand Ice Cream hopes ...
... 22 Alexza,Pharmaceuticals, Inc. (Nasdaq: ALXA ) announced ... presentations given at the Company,s Investor and,Analyst Day on ... Phase 1 and Phase 2 results of the Company,s ... design for AZ-004 (Staccato(R),loxapine), and discuss the role that ...
... Upholds Rights of 10,000 University of California RNs to ... Bargain Over Improved Patient ... victory for public,employees, the California Nurses Association/National Nurses Organizing,Committee today ... of California registered nurses it represents to strike, and to,bargain ...
... in light of a,recent study released by the ... is National STD Awareness Month, Congresswoman Stephanie Tubbs,Jones, ... a bi-partisan,resolution urging the House of Representatives to ... screening and treatment of,sexually transmitted diseases (STD)., ...
... warning to pregnant women that drug use can affect ... -- A combination of THC, the main psychoactive ingredient ... widespread nerve cell death in the brains of young ... Humboldt University, Berlin, administered THC, a synthetic form of ...
Cached Medicine News:Health News:The Quantum Group CEO to Deliver Keynote Address at EDC Life Science Conference 2Health News:The Quantum Group CEO to Deliver Keynote Address at EDC Life Science Conference 3Health News:EDY'S(R) SLOW CHURNED(R) and Giant Food Markets Announce Scoop Day With Sweet Deals to Support the Fight Against Childhood Cancer 2Health News:Alexza to Webcast Investor and Analyst Day Presentations 2Health News:Alexza to Webcast Investor and Analyst Day Presentations 3Health News:CNA/NNOC Wins Key Legal Decision Protecting Right of Public Employees to Strike 2Health News:Tubbs Jones Introduces Resolution Encouraging STD Prevention 2Health News:Pot Plus Alcohol Kills Young Rats' Brain Cells 2
Near point card/newspaper 8 to 48 point type 5 1/2" X 8"....
Rosenbaum card fits in the pocket (3.5 by 6.5") and shows point, Jaeger and distance equivalents from 20/800 to 20/20. Uses numbers, directional Es and XO patterns. For use at 14" (35 mm). Includes f...
Standard reading test. "Value, care for..."...
Standard reading test. "Clearing weather..."...
Medicine Products: